McMaster University, Ivor Wynne Centre
Hamilton, Ontario, L8S 3X3, Canada
NCT Number: NCT05906342
The goal of this clinical trial is to compare features of metabolism in healthy, young adults after they consume four meals of differing fat quantity. The main question this trial aims to answer is how does increasing fat quantity impact glucose tolerance, glucose and insulin metabolism, and hormones involved in hunger. Participant will consume four meals consisting of either 20, 40, 60, or 80% energy from fat.
Looking for future studies?
Notify Me18 year–35 year
All sexes
Interventional
Not applicable
Hamilton, Ontario, L8S 3X3, Canada
The long-term consumption of high-fat foods can lead to unhealthy changes in the functioning of the body, giving rise to metabolic diseases such as type 2 diabetes. Similarly, short-term high-fat diets have also been shown to disrupt how the body performs but there is a lack of information regarding how a single high-fat meal can disrupt metabolism. Comparing meals of different fat quantity, without changing the overall energy intake (calories), will help us understand the short-term effect of fat ingestion on the functioning of the body and whether increasing the amount of fat in a meal is related to the level of dysfunction in the body. Therefore, the investigators will provide participants with four meals of varying fat quantity and in the period following the meal, the investigators will take blood samples to determine any changes that occur in the body in response to different levels of fat.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Provided to participants once throughout duration of study, contains 20% fat
Provided to participants once throughout duration of study, contains 40% fat
Provided to participants once throughout duration of study, contains 60% fat
Provided to participants once throughout duration of study, contains 80% fat
Time frame: Two hours (taking place following the 4-hour postprandial period)
A 2-hour intravenous glucose tolerance test will be performed 4-hours after meal consumption
Time frame: During the 4-hour postprandial period
Postprandial availability of glucose (mM)
Time frame: During the 4-hour postprandial period
Postprandial availability of insulin (µIU/mL)
Time frame: During the 4-hour postprandial period
Postprandial availability of total cholesterol (mmol/L)
Time frame: During the 4-hour postprandial period
Postprandial availability of low-density lipoprotein (mmol/L)
Time frame: During the 4-hour postprandial period
Postprandial availability of high-density lipoprotein (mmol/L)
Time frame: During the 4-hour postprandial period
Postprandial availability of non-esterified fatty acids (mmol/L)
Time frame: During the 4-hour postprandial period
Postprandial concentration of ghrelin (pmol/L)
Time frame: During the 4-hour postprandial period
Postprandial concentration of leptin (pmol/L)
Time frame: During the 4-hour postprandial period
Postprandial concentration of adiponectin (pmol/L)
McMaster University
Other
Investigating the Effect of Acute Fat Ingestion on Glucose Metabolism in Young Healthy Adults: a Dose Response Study
Acronym: AFDR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05093517
Diabetes Mellitus, Diabetes Mellitus, Type 2
San Antonio, Texas, United States
View Trial DetailsNCT03864783
Body Weight, Digestive System Diseases
Hellerup, Denmark
View Trial DetailsNCT05803772
Diabetes Mellitus, Endocrine System Diseases
Levice, Slovenska, Slovakia
View Trial DetailsNCT07618663
Diabetes Mellitus, Endocrine System Diseases
Lahore, Shaikhupura, Pakistan
View Trial Details